Cipla, country’s second-largest pharma company, has asked its IT team to be “paranoid” and take “expert help” to protect the organisations from any possible cybersecurity. The cybersecurity team of Cipla is regularly keeping a track on possible hostile activities including conversations on the dark web. This has come at a time when two large pharmaceutical firms, Dr Reddy’s Laboratories and Lupin witnessed data breach in the recent past.
Cybersecurity experts said that pharma companies into the process of development or production of COVID-19 vaccine should expect a likely ‘Ryuk ransomware’ attack if they haven’t faced one so far. Hyderabad-based Dr Reddy’s Laboratories, on Thursday, faced a cyberattack and was now reviving its networks and data centre security. Vaccine developers and researchers in the US, UK, Canada, Spain and Japan, in the past few weeks, have witnessed cyberattacks.
Dr Reddy’s Laboratories, following a cyberattack today, has isolated all its data centre services. They expect that all services will be resumed normally in next 24 hours. Mukesh Rathi, CIO, of the pharma major said that the cyberattack did not have any major impact on the operations. Dr. Reddy’s and Russia’s sovereign wealth fund have the approval from the Drug Control General of India to conduct human clinical trials for COVID-19 vaccine Sputnik V vaccine in India.